Sirio Pharma Co Ltd
SZSE:300791
Profitability Summary
Sirio Pharma Co Ltd's profitability score is 55/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
Score
Margins
Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.
Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Earnings Waterfall
Sirio Pharma Co Ltd
|
Revenue
|
4.1B
CNY
|
|
Cost of Revenue
|
-2.9B
CNY
|
|
Gross Profit
|
1.3B
CNY
|
|
Operating Expenses
|
-791.8m
CNY
|
|
Operating Income
|
460.4m
CNY
|
|
Other Expenses
|
-124.7m
CNY
|
|
Net Income
|
335.7m
CNY
|
Margins Comparison
Sirio Pharma Co Ltd Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| CN |
|
Sirio Pharma Co Ltd
SZSE:300791
|
6B CNY |
30%
|
11%
|
8%
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
201.6B EUR |
74%
|
20%
|
15%
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
116.4B GBP |
45%
|
18%
|
9%
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR |
52%
|
21%
|
17%
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
34B GBP |
64%
|
23%
|
13%
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
26.8B EUR |
58%
|
16%
|
9%
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
21.1B USD |
73%
|
10%
|
-5%
|
|
| JP |
|
Kao Corp
TSE:4452
|
2.8T JPY |
39%
|
9%
|
7%
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR |
55%
|
20%
|
-3%
|
|
| CN |
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
79.1B HKD |
82%
|
44%
|
37%
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
859.6B INR |
48%
|
15%
|
14%
|
Return on Capital
Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.
Return on Capital Comparison
Sirio Pharma Co Ltd Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Sirio Pharma Co Ltd
SZSE:300791
|
6B CNY |
13%
|
7%
|
10%
|
10%
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
201.6B EUR |
21%
|
12%
|
22%
|
15%
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
116.4B GBP |
30%
|
7%
|
21%
|
14%
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR |
21%
|
14%
|
21%
|
18%
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
34B GBP |
9%
|
4%
|
9%
|
7%
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
26.8B EUR |
11%
|
7%
|
17%
|
14%
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
21.1B USD |
-14%
|
-3%
|
9%
|
10%
|
|
| JP |
|
Kao Corp
TSE:4452
|
2.8T JPY |
11%
|
6%
|
11%
|
9%
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR |
-3%
|
-2%
|
20%
|
-24%
|
|
| CN |
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
79.1B HKD |
36%
|
32%
|
42%
|
137%
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
859.6B INR |
18%
|
12%
|
17%
|
14%
|
Free Cash Flow
Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.
If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.
You don't have any saved screeners yet
